The QualityStocks Daily Wednesday, February 2nd, 2022

Today's Top 3 Investment Newsletters

QualityStocks(SFOR) $0.0589 +64.07%

Schaeffer's(ATI) $22.0200 +17.07%

MarketBeat(CNTX) $2.3500 +9.81%

The QualityStocks Daily Stock List

Dragon Victory International (LYL)

StockMarketWatch, QualityStocks, MarketClub Analysis and BUYINS.NET reported earlier on Dragon Victory International (LYL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dragon Victory International Ltd (NASDAQ: LYL) is a holding firm which is focused on the operation of an online crowdfunding platform that’s reward based in China.

The company has its headquarters in Hangzhou, in the People’s Republic of China and was incorporated in 2015, on June 19 by Yu Han. It serves consumers across the globe as well as idea generators, start-up ventures, medium and small sized companies.

The firm operates through these segments: Taikexi and Longyun. The Taikexi segment under which Finder’s fees services and Auto-Parts procurement services operate, is engaged in the provision of logistics services and auto parts sourcing while the Longyun segment under which the Crowdfunding platform service and the Incubation Services operate, is involved in the incubation and crowdfunding business.

The company also offers business incubation services related to strategic planning, sales and marketing and general and guidance resources in ancillary services, such as assisting with feasibility studies, operations, accounting, legal, human resources and other types of services. It also provides procurement services to auto-repair businesses that need auto parts from suppliers. This is in addition to operating 5etou, which allows projects looking for finances to connect with sources of finance.

The enterprise uses blockchain and smart contract technology in most of its dealings and may soon get into the cryptocurrency space, which is a burgeoning field at the moment. This move would not only help the firm expand its reach into new markets but also allow it to invest in new ventures, which would be beneficial to its stocks and its shareholders.

Dragon Victory International (LYL), closed Wednesday's trading session at $1.24, up 18.0952%, on 407,635 volume with 1,087 trades. The average volume for the last 3 months is 406,133 and the stock's 52-week low/high is $0.8701/$3.88.

Strikeforce Technologies (SFOR)

QualityStocks, PennyStocks24, SmallCapFinancialWire, The Bull Report, Smart Penny Stocks, OTCPicks, Whitehotstocks, FeedBlitz, Promotion Stock Secrets, Street Beat, Atomic Trades, PennyTrader Publisher, MadPennyStocks, HotOTC, Penny Stock Rumble, PennyInvest, CoolPennyStocks, BullRally, BestPicksEver, PennyStockVille, MicroStockProfit, StockRich, Wallstreetlivechat, Top Gun, StockEgg, The Stock Psycho, Pumps and Dumps, AddictivePennyStocks, TopPennyStockMovers, Top Stock Picks, Early Bird, TheMicrocapNews, Free Hot Penny Stocks, The PennyStock Picks, PricelessPennyStocks, OTC Advisors, Penny Stock Finder, StockHideout, PennyStockLive,, Stock Preacher, PennyStockShark, Actual Gains, Real Pennies, Wise Alerts and Stocks Gone Wild reported earlier on Strikeforce Technologies (SFOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Strikeforce Technologies, Inc. (OTC: SFOR) is a cybersecurity firm that is engaged in the provision of software development and devices across the globe.

The company has its headquarters in Edison, New Jersey and was incorporated in August 2001 by George Waller and Mark Joseph Corrao. Prior to its name change in September 2004, the firm was known as StrikeForce Technical Services Corporation.

It markets its products to retail distributors, multi-level marketing groups, government agencies, automotive and e-commerce companies, technology service providers, virtual private network providers, legal services, healthcare related and financial service firms, as well as the enterprise market in general. These products are sold directly to consumers through original equipment manufacturer agreements, affiliates, third party agents, resellers, distributors and the internet.

The firm’s products, which encompass areas such as biometric layering, remote access and identity management, include privacyLok, safeVchat, mobile trust, guarded ID and protect ID. Apart from providing products that help protect businesses against breaches and data loss, and safeguarding consumers while shopping and banking online, the firm also provides a suite of network security products that use proprietary technology, to consumers and businesses that offer endpoint protection and out of band authentication. It also offers mobile device security on Android and Apple devices and provides professional services, which include support and consulting services.

The company recently acquired another company that is also engaged in the provision of innovative data, privacy and cyber protection solutions, known as Cybersecurity Risk Solutions LLC. This acquisition will allow the company to provide the marketplace with cost-effective cyber solutions for reducing security risks while also strengthening and growing their channel distribution strategies.

Strikeforce Technologies (SFOR), closed Wednesday's trading session at $0.0589, up 64.0668%, on 51,028,281 volume with 2,459 trades. The average volume for the last 3 months is 51.028M and the stock's 52-week low/high is $0.03/$0.3289.

Entasis Therapeutics Holdings (ETTX)

MarketBeat, MarketClub Analysis, StockMarketWatch, QualityStocks and BUYINS.NET reported earlier on Entasis Therapeutics Holdings (ETTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) is a clinical-stage biopharmaceutical firm that is engaged in discovering, developing and commercializing new antibacterial products for the treatment of severe infections caused by drug resistant bacteria in the U.S.

The firm has its headquarters in Waltham, Massachusetts and was incorporated in May 2015. It operates as part of the pharmaceutical manufacturing industry in the health sector and serves consumers in the U.S. The company has half a dozen firms in its corporate family.

The enterprise is party to a collaboration agreement with Global Antibiotic Research and Development Partnership which entails developing and commercializing a candidate dubbed zoliflodacin; and a collaboration and license agreement with Zai Lab Co. Ltd, for developing subbactam-durlobactam and durlobactam.

The company’s product pipeline is made up of a drug candidate dubbed ETX0462, which is in its pre-clinical stage and has been developed for treating multi-drug resistant infections; an oral drug known as ETX0282CPDP, currently in its phase 1 clinical trial developed for treating urinary tract infections and a new orally administered molecule dubbed Zoliflodacin, which is currently undergoing phase 3 clinical trials indicated for treating uncomplicated gonorrhea. In addition to this, the company also develops SUL-DUR, a new IV antibiotic undergoing phase 3 clinical trials for treating Acinetobacter baumannii.

The firm recently released their financial results for the first quarter of 2021 which highlight the progress the firm has made in its pipeline. Its CEO noted that this year will be transformative for the firm, which is working on becoming a commercial stage firm. The move coupled with the firm’s formulation will encourage more investments into Entasis Therapeutics Holdings.

Entasis Therapeutics Holdings (ETTX), closed Wednesday's trading session at $1.8, up 24.1379%, on 10,290,128 volume with 19,940 trades. The average volume for the last 3 months is 10.205M and the stock's 52-week low/high is $1.40/$3.8799.

The 4Less Group, Inc. (FLES)

QualityStocks and Emerging Markets reported earlier on The 4Less Group, Inc. (FLES), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The 4Less Group, Inc. is an e-commerce auto parts sales business. With its acquisition of the URL, the Company is concentrating all efforts and resources on building out a flagship multi-vendor automotive parts marketplace. It’s belief is that this will have the potential to list and sell millions of parts. This will include automotive specialty equipment parts and accessories, targeted "niche" web sites, and potentially a used auto parts exchange, eventually. The 4Less Group is based in Las Vegas, Nevada.

The Company’s products are grouped by brand in one of a kind interactive niche web sites. This to enable its customers to compare and shop efficiently. This allows its customers to find, fast and accurately, the correct after-market parts for their Jeep, truck, or SUV (Sports Utility Vehicle).

The 4Less Group’s websites include,,, and Furthermore, websites include,,, and

The 4Less Group previously announced that it expects to commence the beta testing with multiple vendors of its auto parts marketplace during Q1 of 2021. The design of this digital multi-vendor platform has been with manufacturers and resellers in mind.

Moreover, it is built off an enterprise class feature-rich platform, which is one of the top platforms for open commerce innovation. Company Management strongly believes that is the ideal platform for their marketplace as it offers a degree of scalability and granularity required for an undertaking such as this.

Mr. Christopher Davenport, Founder and President of Auto Parts 4Less, Inc., The 4Less Group's wholly-owned subsidiary, said in October, Our team has made fantastic progress so far; as a result of their hard work we are confident that we will be able to open up the beta platform to manufacturers to get their direct input as we continue to innovate in this space. When finished our marketplace will be a very scalable and robust platform that will allow thousands of manufacturers and resellers to list their parts on the platform for selling direct to consumers."

The 4Less Group, Inc. (FLES), closed Wednesday's trading session at $0.9799, up 35.1586%, on 138,008 volume with 111 trades. The average volume for the last 3 months is 138,008 and the stock's 52-week low/high is $0.705/$3.45.

Exicure Inc. (XCUR)

PCG Advisory, QualityStocks, MarketBeat, StockMarketWatch and InvestorsUnderground reported earlier on Exicure Inc. (XCUR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Exicure Inc. (NASDAQ: XCUR) (FRA: 2H0) is a clinical-stage biotechnology firm that is focused on the development of therapeutics for genetic disorders, inflammatory illnesses, immune-oncology and neurology diseases.

The firm has its headquarters in Chicago, Illinois and was incorporated in June 2011 by Colby Shad Thaxton and Chad A. Mirkin. It operates as part of the medical and diagnostic laboratories industry, under the healthcare sector. The firm serves consumers in the United States.

The company develops its therapeutics based on its proprietary spherical nucleic acid (SNA) technology. It is party to a collaboration agreement with Ipsen S.A., which entails the development and commercialization of new spherical nucleic acids for Angelman syndrome and Huntington’s disease; a development and license agreement with Dermelix LLC, which involves developing and commercializing its technology to treat netherton syndrome; and an option, license and collaboration agreement with Allergan Pharmaceuticals International Ltd, entailing the development of SNA-based hair loss disorder treatments.

The enterprise’s product pipeline is made up of an SNA which targets TNF dubbed AST-005, for treating mild to moderate psoriasis; an SNA targeting the mRNA encoding IL-17 receptor alpha known as XCUR17; and an SNA-based therapeutic candidate dubbed XCUR-FXN, which is in preclinical trials evaluating its effectiveness in treating Friedreich’s ataxia. It also develops AST-008, for the treatment of patients with advanced solid tumors.

The firm is focused on aligning its research and development resources to support the development and continued advancement of some of its preclinical products as well as some of its undisclosed therapeutic candidates.

Exicure Inc. (XCUR), closed Wednesday's trading session at $0.2445, up 16.4286%, on 39,462,274 volume with 23,400 trades. The average volume for the last 3 months is 39.462M and the stock's 52-week low/high is $0.1415/$2.83.

Yoshitsu Co. (TKLF)

We reported earlier on Yoshitsu Co. (TKLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yoshitsu Co. Ltd (NASDAQ: TKLF) is a wholesaler and retailer of various Japanese products, including health and beauty products.

The firm has its headquarters in Tokyo, Japan and was incorporated in 2006, on December 28th. The firm serves consumers around the globe, with a focus on Japan, the United States, Canada and China.

The company’s objective is to become a global firm with high information technology and product capabilities to bring new contributions and value to the world. It has ten directly operated physical stores in Japan and twenty-two online stores in China and Japan. It also has six franchise stores in Canada and nine of the same in the United States, as well as two franchise stores in Hong Kong; and one franchise store in the U.K. In addition to this, the company has about 115 wholesale customers in Canada, U.S., China and Japan.

The enterprise provides beauty products, which include body care, fragrance, skin care, cosmetic products, among other products. Its health products include nutritional supplements, over the counter drugs, medical devices and supplies. The enterprise’s other products include food products, home goods, lingerie and alcoholic beverages. It sells its products via wholesale customers, online stores and directly operated physical stores, as well as franchise stores.

The company, which recently launched its IPO, plans to add franchise stores, open new directly-operated physical stores, and improve logistics systems and distribution centers. It also plans to market its brand extensively, which will help extend the company’s consumer reach and positively influence investments into the company, which will be good for its growth.

Yoshitsu Co. (TKLF), closed Wednesday's trading session at $3.55, off by 0.560224%, on 7,253,243 volume with 21,320 trades. The average volume for the last 3 months is 7.192M and the stock's 52-week low/high is $2.50/$43.00.

Pipestone Energy (BKBEF)

Trades Of The Day and MarketBeat reported earlier on Pipestone Energy (BKBEF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pipestone Energy Corp (OTC: BKBEF) (TSE: PIPE) (FRA: 2LA) is an oil and gas exploration and production firm that is focused on exploring for, developing and producing oil and natural gas liquids, which include propane, butane and condensate, which are collectively referred to as liquids.

The firm has its headquarters in Calgary, Canada and was incorporated on 2019, on January 4th. Prior to its name change, the firm was known as Blackbird Energy Inc. It operates as part of the support activities for the mining industry. The firm serves consumers around the globe.

The company values the partnerships that it is developing within its operating community and is committed to building long term value for its shareholders. It is focused on the development of its liquid-rich assets in the Pipestone area of the Alberta region. The company operates as a subsidiary of Canadian Non-Operated Resources LP.

The enterprise specializes in the development of natural gas and natural gas liquids in the Montney geological formation which covers 130,000 km2,running 700 km south to north and crossing the provincial boundary between Northeast British Columbia and Northwest Alberta. Its Montney asset is condensate-rich, with decades of high value condensate development potential. Its Pipestone Wembley project covers about 90,000 acres and is situated outside of Grande Prairie, Alberta.

The company recently achieved independent certification of its entire production portfolio, under the E0100 Standard for Responsible Energy Development. This certification will encourage more investments into the company, as it aligns with its fundamental goals of responsible development, stakeholder service and commitment to creating value for its shareholders.

Pipestone Energy (BKBEF), closed Wednesday's trading session at $3.732, off by 1.5303%, on 14,679 volume with 19 trades. The average volume for the last 3 months is 14,679 and the stock's 52-week low/high is $0.44/$3.90.

Medical Care Technologies (MDCE)

HotShotStocks, OTCPicks,, StockRockandRoll,, StockLockandLoad, HotStockCafe, Hot Shot Stocks, QualityStocks, PennyStocks24, Penny Stocks On Steroids, Pumps and Dumps, PennyStock Tweets, Penny Stocks Expert, Investor News Source, Penny Stock Gains, PennyTrader Publisher, MicrocapVoice, ResearchOTC, WallstreetSurfers, CrazyPennyStocks, Stockgoodies, 24-7 Stock Alert, Darth Trader, Penny Stock Market Bulls, StockEgg, The Stock Psycho, We Beat Wallstreet, Real Pennies, POSstocks, Skylab Global Investments, SmallCapVoice, Penny Stock Explosion, FeedBlitz, TheMicrocapNews, WallstreetsHotteststocks, HotOTC, fusionspicks, Smart Business Investing, Damn Good Penny Picks, Stock Rich, CoolPennyStocks, AwesomeStocks, Global Equity Report, MarketWireStocks, MoneyTV, Stockpalooza, Penny Invest, Penny Picks, Psycho Penny Stocks, PREPUMP STOCKS, Penny Stock Newsletter, Penny Stock Rumble, Stocks To Watch, PennyStocks Forever, The Penny Stock Alert and marketwirepress reported earlier on Medical Care Technologies (MDCE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medical Care Technologies Inc. (OTC: MDCE) is a development stage firm that is focused on operating and opening integrated health and wellness centers for children.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2007, on February 2nd. The firm serves consumers in China.

The enterprise offers family healthcare services and eHealth information technology solutions. Its services include the development and distribution of healthcare wellness products, eHealth solutions and integrated healthcare clinics. The development and distribution of healthcare wellness products includes therapeutic devices and equipment, nutraceuticals and wireless healthcare monitoring devices. The eHealth solutions offer the healthcare smartcard and medical clinic management system and the cloud computing electronic health records system. On the other hand, the integrated healthcare clinics facilitate owning family medical clinics with Health Information Technology setup and support. The enterprise also distributes and sells nutraceutical and pharmaceutical products as well as other products, which include family care products, personal care products, herbal products and over-the-counter drugs. It serves pharmaceutical companies, retail pharmacies, physicians' office practices, hospitals, industrial and food microbiology labs and consumers. The enterprise provides its products via its website, retail pharmacies and its pediatric health and wellness centers, as well as directly to end-users via independent sales representatives and through sales and distribution channels.

The company is planning to rebrand and employ a new strategy that will lead it to even greater heights. This new direction will, in addition to bringing in more investors into the company, boost the company’s growth significantly.

Medical Care Technologies (MDCE), closed Wednesday's trading session at $0.0125, up 15.7407%, on 6,604,662 volume with 116 trades. The average volume for the last 3 months is 6.605M and the stock's 52-week low/high is $0.0004/$0.03.

Payoneer Global (PAYO)

MarketBeat reported earlier on Payoneer Global (PAYO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Payoneer Global Inc. (NASDAQ: PAYO) is a commerce-enabling and cross-border payment platform.

The firm has its headquarters in New York and was incorporated in 2005. It operates as part of the activities related to the credit intermediation industry. The firm has twelve companies in its corporate family and serves consumers around the globe.

The company’s cross-border payments platform empowers and enables users to receive payments from global networks and marketplaces directly to their account, access said funds, make purchases in-store or online, pay other Payoneer customers without charge and transfer funds to a local bank account.

The enterprise provides various services, including risk management, merchant services, tax solutions and cross-border payments. Its platform affords service providers and web development companies options to pay and get paid by marketplaces and firms globally; allows freelancers to get paid by or pay marketplaces and companies globally; and offers a solution to content creators, publishers, affiliates and online advertisers to get paid by digital marketing platforms. It also offers its platform to online sellers to receive payments from e-Commerce marketplaces; access funds directly to local bank account; monitor performance of multiple stores at one place; view payment history for e-commerce sites and get payments for goods purchased in-store. This is in addition to providing working capital services.

The firm’s partnership with Awin Group was recently expanded in an effort to streamline international payments and fuel growth for publishers. This move will help Payoneer empower small businesses globally while making international payments more secure, more cost effective and easier, which may boost its business and significantly increase its revenues.

Payoneer Global (PAYO), closed Wednesday's trading session at $5.23, off by 3.1481%, on 2,543,027 volume with 15,100 trades. The average volume for the last 3 months is 2.543M and the stock's 52-week low/high is $4.37/$11.20.

Abaxx Technologies (ABXXF)

We reported earlier on Abaxx Technologies (ABXXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Abaxx Technologies Inc. (OTCQX: ABXXF) (FRA: 36N0) is a financial technology company which is focused on the development of software tools for finance professionals and commodity traders to transact faster, trade, communicate and manage risk.

The firm has its headquarters in Toronto, Canada and was incorporated in 2003, on August 8th. It operates as part of the computer systems design and related services industry. The firm serves consumers around the globe, with a focus on Canada.

The company is focused on finding suitable solutions for the commercial needs of the market. It is developing the technological infrastructure and applications for the Environmental, Social and Governance Economy.

The enterprise is the majority shareholder of a commodity futures exchange known as Abaxx Singapore Pte. Ltd, which is seeking Approved Clearing House status with the Monetary Authority of Singapore and final regulatory approval as a Recognized Market Operator. Its commoditization of Trust is a software architecture, which consists of software technologies including self-sovereign digital identify, deep learning and natural language processing, smart contracting languages and protocols and encrypted content-addressing distributed file systems. The enterprise also offers clearing and trading software, data and financial messaging services, and access management and digital identity software. It is also involved in the development of a regulated commodity futures exchange.

The firm recently announced that it would be unveiling a new multi-media platform, which would comprise of a podcast on which executives of finance, technology and commodities as well as entrepreneurs could share their views on different inadequacies and discuss the state of global markets. The launch of this platform may have a positive impact on the firm’s investment appeal, which will be good for its growth.

Abaxx Technologies (ABXXF), closed Wednesday's trading session at $2.34, up 1.2943%, on 103,666 volume with 122 trades. The average volume for the last 3 months is 103,666 and the stock's 52-week low/high is $2.05/$3.59.

Bassett Furniture Industries, Inc. (BSET)

The Online Investor, StreetInsider, TopStockAnalysts, MarketBeat, Zacks, StreetAuthority Daily,, QualityStocks, Street Insider, SmarTrend Newsletters, Daily Dividends, The Growth Stock Wire, ProfitableTrading, PennyToBuck, TradersPro, Trades Of The Day, InvestorPlace, Daily Trade Alert and Schaeffer's reported earlier on Bassett Furniture Industries, Inc. (BSET), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Earnings Release

Bassett Furniture Industries (NASDAQ: BSET) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “4Q:F22 Results Above Expectations; Adjust F2022, F2023 EPS Estimates As BSET Divests Zenith Logistics; Maintain Moderately Risky Rating, $36 Price Target.”

Click here to access the full report.

About Bassett Furniture Industries, Inc.

Bassett Furniture Industries is a leading manufacturer and marketer of high-quality home furnishings. With 97 company- and licensee-owned stores at the time of this release, Bassett has leveraged its strong brand name in furniture into a network of corporate and licensed stores that focus on providing consumers with a friendly environment for buying furniture and accessories. Bassett’s retail strategy includes stylish, custom-built furniture that features the latest on-trend furniture styles, free in-home design visits, and coordinated decorating accessories. Bassett also has a traditional wholesale business with more than 700 accounts on the open market, across the United States and internationally and a logistics business specializing in home furnishings. Please visit

Bassett Furniture Industries, Inc. (BSET), closed Wednesday's trading session at $17.76, off by 0.782123%, on 125,961 volume with 1,846 trades. The average volume for the last 3 months is 125,961 and the stock's 52-week low/high is $13.16/$37.00.

Arch Capital Group Ltd. (ACGL)

GorillaTrades, MarketBeat, Zacks, StreetInsider,, MarketClub Analysis, Daily Trade Alert, SmarTrend Newsletters, Schaeffer's, Louis Navellier, Market Report, StockMarketWatch, Trades Of The Day, The Street, Top Pros' Top Picks, Greenbackers, InvestorPlace, Investopedia, Barchart, Investing Lab, Wall Street Greek, InvestmentHouse, Market Intelligence Center Alert, AllPennyStocks, Uncommon Wisdom, Trading Markets, Navellier Growth and Kiplinger Today reported earlier on Arch Capital Group Ltd. (ACGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of Arch Capital Group Ltd. (NASDAQ:ACGL) traded at a new 52-week high today of $47.76. This new high was reached on below average trading volume as 207,000 shares traded hands, while the average 30-day volume is approximately 1.5 million shares.

In the past 52 weeks, Arch Capital Group Ltd. share prices are bracketed by a low of $31.28 and a high of $47.76 and is now at $47.51, 52% above that low price.

Based on a current price of $47.51, Arch Capital Group Ltd. is currently 33.4% above its average consensus analyst price target of $31.64.

Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and South Africa. The business operates through three segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients worldwide across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit

Arch Capital Group Ltd. (ACGL), closed Wednesday's trading session at $47.94, up 1.3102%, on 1,818,753 volume with 19,400 trades. The average volume for the last 3 months is 1.77M and the stock's 52-week low/high is $32.26/$47.985.

The QualityStocks Company Corner


The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2022 Sequire Metals & Mining Conference, a preeminent virtual investor event. The conference took place on Jan. 27 and featured presentations from more than 70 premier metals and mining stock market companies, as well as talks with industry experts. SRAX has announced the availability of replays from the conference and invited interested parties to visit to view presentations and keynotes from the event. To view the full press release, visit

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.


BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.


Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $5.01, up 0.400802%, on 106,393 volume with 866 trades. The average volume for the last 3 months is 106,393 and the stock's 52-week low/high is $3.25/$7.29.

Recent News

Save Foods Inc. (NASDAQ: SVFD)

The QualityStocks Daily Newsletter would like to spotlight Save Foods Inc. (NASDAQ: SVFD).

Save Foods (NASDAQ: SVFD), an agri-food tech company specializing in eco crop protection designed to reduce food waste and ensure food safety, will be presenting at next month’s Aegis Capital Corp. Virtual Conference. The three-day conference is scheduled for Feb. 23­–25, 2022. Save Foods will present a company overview during the event. Those interested can request access to the presentation from Aegis during the conference. In addition, the slide deck from the presentation will be available on Save Food’s website following the event. To view the full press release, visit

Save Foods Inc. (NASDAQ: SVFD) is an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables. The company is focused on addressing two of the most significant challenges faced by the industry: (1) food waste and loss, and (2) food safety.

Fungi like mold and yeast, as well as foodborne pathogens, are typically responsible for fresh produce spoilage and foodborne illness. Save Foods’ integrated solutions improve safety, freshness and quality every step of the way, from field to fork. The company’s natural products control human and plant pathogens, allowing growers, packers and food retailers to reduce waste and boost revenues. More food ends up on consumers’ plates, and less ends up in landfills.

Save Foods’ products use all-natural ingredients to protect fresh produce from microbial spoilage and pathogens with zero toxicity. The company’s treatments leave no harmful residues on produce or in the environment and maintain product freshness over time. Fresh produce treated with Save Foods’ products can already be found in supermarket chains across the U.S. and Europe. Those chains have reported that the company’s products are reducing fruit spoilage by 50% on average at the retail level. With no need for additional steps in the treatment process nor special equipment, Save Foods’ products are easy to implement and come in versatile applications suitable for the different stakeholders along the food supply chain.

Initial applications for the company’s offerings include post-harvest treatments in fruit and vegetable packing houses that process citrus, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of chemicals and their residues, Save Foods’ products not only prolong shelf life; they also ensure safe, natural and healthy food. Save Foods has the first green products that could realistically replace the different chemicals used today in food treatment while controlling waste and food safety.

Products & Technology

  • SavePROTECT or PeroStar, a processing aid added to fruit and vegetable wash water and used in post-harvest treatment;
  • SF3HS and SF3H, post-harvest treartment solutions to control both plant and foodborne pathogens;
  • SpuDefender, for controlling post-harvest potato sprouts; and
  • FreshPROTECT, for controlling spoilage microorganisms on post-harvest citrus.

Save Foods’ products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of sanitizers and fungicides at low concentrations in a non-organic setting. The combination eliminates fungicide residues or reduces them to levels below the established Maximum Residue Levels (MRLs). The company’s fruit and vegetable wash is odorless and does not irritate human eyes, skin or airways. Save Foods’ blend does not leave any residues of toxicological concern on the treated surface of produce, and all its ingredients are classified by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS). There are 7 patent families related to Save Foods’ technology.


The company’s products have been commercially validated on citrus, mangos, avocados, pears, bell peppers, microgreens and various fresh cut vegetables. Save Foods is in the validation process for bananas, apples, figs, berries, lettuce, papayas and more. The company is also validating the efficacy of its products for pre-harvest treatment, starting with citrus trees.

Market Outlook

The world population is expected to grow to almost 10 billion by 2050, boosting current agricultural demand by some 50%. Providing healthy and safe food for the world’s population is one of the biggest challenges of the 21st century.

Globally, around 664 million tons of fresh fruits and vegetables are lost every year from field to fork, wasted by spoilage, and almost one in 10 people globally falls ill every year from eating contaminated food, with an estimated resulting cost around $90 billion.

Disposing of all that wasted food requires additional expense and harms the environment with resulting greenhouse gas emissions. The post-harvest food treatment market was valued at $1.5 billion in 2019 and is expected to grow to $2.3 billion by 2026, achieving a CAGR of 6.5%.

Management Team

David Palach is CEO of Save Foods. He spent over a decade with Intel Israel, where his last position was Manager of Business Development for Israel and Europe. Prior to that, he served as a controller of two of Intel’s largest factories in Israel, where he supervised a budget of over $1 billion. He also served as the CEO of B-Pure Corporation Ltd., a management and maintenance company involved in protecting and improving the environment. During his tenure, he helped turn around several struggling subsidiaries and made them profitable.

Vered Raz Avayo is the company’s CFO. Before joining SaveFoods in 2018, she spent more than 10 years as CFO at LGC, the Leviev Group of Companies. She has operated her own financial and business consultancy and has served as a director for a number of public companies in Israel.

Dan Sztybel is CEO of SaveFoods Ltd., the Israeli subsidiary of Save Foods Inc. He previously led the Life Sciences Advisory at EY Israel and early on recognized the potential of Israel as a center of innovation in the digital health space. He has been an adviser on digital health strategy to large pharmaceutical companies and is a cofounder of MyndYou, a digital health start-up focusing on cognitive impairment. He is also a co-founder of the conference, the largest digital health conference in Israel.

Dr. Neta Matis is Vice President of R&D at Save Foods Ltd the Israeli subsidiary of Save Foods Inc . She holds a Ph.D. in organic chemistry and an MBA from Tel Aviv University. Prior to joining Save Foods in 2019, she held multiple research chemist and product development roles at Verdia Inc. and its parent company, Helsinki-based Stora Enso Oyj.

Nimrod Ben Yehuda is the founder and CTO of Save Foods Ltd. He was previously the CEO/CTO of Swissteril Water Purifications Ltd. He has also been CEO at Nir Ecology Ltd., and was Joint-CEO at NitroJet Ltd.

Dr. Art Dawson is the U.S. Business Manager for SaveFoods Inc. He has been president of The Dawson Company, which focuses on creating sales opportunities for new agricultural technologies, previously Dr. Dawson held senior industry positions like General Manager Worldwide of the Decco , the Post Harvest Division for Elf Atochem. He holds a Ph.D. in Plant Physiology from UC Riverside and is licensed in California as an agricultural Pest Control Advisor.

Save Foods Inc. (SVFD), closed Wednesday's trading session at $4.4, up 1.1494%, on 62,098 volume with 293 trades. The average volume for the last 3 months is 61,244 and the stock's 52-week low/high is $3.4001/$30.10.

Recent News

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

The QualityStocks Daily Newsletter would like to spotlight BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

  • BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clients
  • Company deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North America
  • Company actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified health and wellness beverage and natural products company developing and manufacturing a diverse portfolio of alkaline, plant-based, and cannabinoid beverages and supplements for in-house brands and white-label clients alike. Founded in 2017, BevCanna was quick to leverage a unique value that its team of established beverage experts brings to the table – deep knowledge of consumer preferences and buying behavior that inspires the creation of products that appeal to consumers at a mass scale. Earlier this week, the narcotics board in Thailand announced that it would be removing marijuana from its list of controlled drugs, which would allow households in the country to grow the herb. Thailand was the first country in southeast Asia to legalize cannabis for research and medical use in 2018. Under this new law, individuals can grow marijuana at home after they have notified the local government. However, the country’s Health Minister Anutin Charnvirakul stated in an interview that the marijuana grown can’t be used for commercial purposes if one hadn’t obtained a license. As additional countries and jurisdictions bring cannabis prohibition to an end, more individuals will have access to marijuana-based offerings, such as BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) suite of health & wellness products.

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale.

BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands.

Based in British Columbia, Canada, BevCanna was founded in 2017.

End-to-End Turnkey Beverage Manufacturing Solutions

BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

  • Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
  • Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
  • Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
  • Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
  • Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands

BevCanna’s in-house brands include Pure Therapy and TRACE.

Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (CBD) products, throughout North America and Western Europe.

Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise.

TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels.

Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness.

TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots.

In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages.

Market Outlook for Cannabis-Infused Beverages

In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (

The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces.

Management Team

Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand.

John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd.

Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years.

Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise.

Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL).

Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years.

Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries.

Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY).

BevCanna Enterprises Inc. (OTCQB: BVNNF), closed Wednesday's trading session at $0.1587, up 0.379507%, on 27,527 volume with 17 trades. The average volume for the last 3 months is 27,527 and the stock's 52-week low/high is $0.1309/$1.20.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is positioned in the growing legal cannabis market, which is expected to see an estimated 16.6% growth in the coming years. “At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a ‘landmark year’ for the company, telling shareholders that in 2021 SGMD would ‘continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins,’” a recent article reads. “The strategy for 2021 appears to have paid off as Sugarmade’s Nug Avenue hub in the Los Angeles metro area has grown dramatically since opening in March 2021. In addition, the company is making significant progress on opening a second Nug Avenue location and has implemented new cannabis delivery technology to establish a competitive advantage in its core delivery zone. Finally, in 2021 the company moved closer to its goal of first planting at the large 640-acre outdoor cultivation site associated with its recently acquired Lemon Glow subsidiary.” To view the full article, visit:

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.


Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Wednesday's trading session at $0.0009, up 5.8824%, on 14,969,220 volume with 63 trades. The average volume for the last 3 months is 14.969M and the stock's 52-week low/high is $0.0007/$0.02.

Recent News


The QualityStocks Daily Newsletter would like to spotlight reAlpha

reAlpha, a cutting-edge technology company with a goal to empower everyone with the ability to invest in the $1.2 trillion short-term rental market, has announced the continued growth of its first office in India, situated in Bengaluru. reAlpha has generated great momentum in the India market, with more than 2,000 investors having expressed interest in its Regulation A+ funding round, alongside potential investors from 66 other countries. The Bengaluru office, currently looking to add members to its team of 10, assists with digital marketing and financial and accounting services. “What we are really excited about at reAlpha is the dynamic culture,” said reAlpha’s Chief Marketing Officer Christie Currie. “We feel that we have created an energy that transcends geographic and cultural boundaries, and believe that is the most powerful thing a young company like us can have. I am eager to bring more skills, perspectives, and ideas to the table as we continue to expand our team in India and across the globe.” To view the full press release, visit

reAlpha is the Robinhood of Airbnb investments, representing the intersection of modern technology and lasting assets. A new wave of investment opportunities in real estate has emerged, and Airbnb short-term rentals are changing hospitality and travel on a global scale. Previously, only accredited investors have had access to the best real estate deals, but reAlpha is democratizing this lucrative new model, empowering anyone to generate wealth as a reAlpha member. reAlpha uses its proprietary, disruptive technologies to level the playing field, unraveling the industry’s high barriers to entry and bringing the power of real estate investing to the “99 percent.”

The company’s unique model allows investors to benefit from both the superior returns of short-term rental income and increases in property value through renovation and appreciating markets. reAlpha likens this double investment return to seeing two desserts on a dinner menu and ordering both.

The company seeks to open up access to real estate investing by letting regular people buy fractional ownership of short-term rentals using reAlpha’s smartphone app. The reAlpha app simplifies the real estate investing process. In the app, investors can check out the company’s most current properties offered for investment. If they choose to invest, they become members of a syndicate invested in a specific short-term rental property. Syndicate members receive quarterly dividend payments from rental revenue generated by the property in which they invested. The reAlpha model merges the most historically stable asset – real estate – with technology and the sharing-economy business model of the future – Airbnb.

The company handles all property management functions and believes short-term rentals are no longer purely transactional and occupancy-driven. reAlpha reimagines the entire guest experience end-to-end to make sure the reAlphaHouse is the ultimate on-demand rental property. The company plans to implement various technologies, including smart locks, voice-activated electronics, home automation systems, and innovative furnishings, to create an unparalleled guest experience. When guests have exceptional stays, investors enjoy maximized profits.

How it Works

reAlpha has identified specific markets in which to purchase short-term rentals across the globe. The company prefers to buy 100 to 500 properties in each market. reAlpha uses artificial intelligence technology, dubbed reAlphaBRAIN, to select “unicorn properties,” the best available opportunities in the market for investment. The AI software can quickly evaluate thousands of property listings based on 25+ factors and assign each a reAlphaScore, projecting how Airbnb Viable the property is, as well as its projected value in the housing market.

For a minimum investment of $2,500, an investor can purchase equity in a specific reAlpha property, similar to how they would buy stock or shares in a company. reAlpha matches the investor with other like-minded backers to form a syndicate, so together they can cover a down payment on the selected property. Investment properties usually require a down payment of 25 percent of the purchase price, but, with reAlpha properties, the down payment is only 10 percent because of the company’s relationships with lenders, making the initial investment more affordable.

reAlpha maintains a majority stake in each investment syndicate, retaining 51 percent ownership in each purchased property and ensuring their interests are always aligned with investing members. Properties are typically refinanced after 12 to 16 months, freeing equity for reinvestment in additional properties. The company uses its AI software to predict optimum timing to sell properties in order to extract maximum value for investors. Gains are reinvested in additional properties. However, reAlpha also believes that real estate investing is more than financial returns. It includes the pride of ownership and the freedom of financial security. reAlpha members have access to their property when it is not rented out on Airbnb. The company is driven every day to create not only lucrative returns for its members but also to deliver exceptional experiences and positive impact in the communities in which reAlpha lives and operates.


Market Outlook

There are an estimated 7.4 million short-term rental properties worldwide. The total asset value of this global market is projected at $1.2 trillion. In the U.S. there are about 1.8 million short-term rental properties. These have an estimated asset value of $933 billion. Brain Chesky, the CEO of Airbnb, recently stated that there is a shortage of properties to meet demand and that the company will need “millions of more hosts.” reAlpha is projecting that the company and its investors will own 5,000 short-term rental investment properties by 2025. reAlpha forecasts annual revenue of $434 million by 2025.

Management Team

Giri Devanur is the CEO and co-founder of reAlpha. Prior to founding reAlpha, he served as president and CEO of enterprise software company Ameri100 Inc. from its founding in 2013. He scaled Ameri100 from zero to $50 million in revenue and took the company public in 2017. That same year, he was named E&Y Entrepreneur of the Year. He immigrated to the U.S. with virtually no possessions and $65 in the bank. He earned a Master’s in Technology Management from Columbia University, where he continues to mentor aspiring entrepreneurs.

Monaz Karkaria is the COO and co-founder of reAlpha. Prior to reAlpha, she founded real estate management firm Ben Zen Properties LLC. She has also worked in branch operations for Citibank. Before her involvement in Citibank, she worked at Berlitz in Sao Paulo, Brazil, as an ESL business coach and consultant for various international business clients like GE, Google, PepsiCo and others. She began her career in sales and marketing at Smith & Nephew Dubai. She is also a popular real estate coach and speaker.

Mike Logozzo is the CFO of reAlpha. Prior to joining the company, he served as Managing Director, Americas for innovation advisory firm L Marks. Before that, he was General Manager, Financial Services Operations, Americas Region for BMW Group Financial Services, where he also held Special Projects Manager and CIC Strategy Manager positions.

Christie Currie is the CMO of reAlpha. Previously, Christie launched her own business in the MedTech space, Zandaland, where she worked closely with large enterprises and health care systems. Currie’s work in the startup community led her to London-based corporate innovation firm L Marks, where she led world-leading corporations in retail, supply chain and logistics, and health care to identify strategic areas of need and successfully engage industry-disrupting startups. Currie has mentored hundreds of these startups, helping them to align their technology solutions with market needs.

Recent News


Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor ("PDE5 inhibitor") sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes the recent study findings lead to the development of faster, better-acting sildenafil oral formulations. The animal study was conducted at a third-party independent laboratory located in the United States and involved 20 male Sprague-Dawley rats (two groups of 10 rats each) being treated with a single dose of the DehydraTECH-sildenafil and Control-sildenafil formulations. To view the full press release, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $3.86, off by 8.9623%, on 833,777 volume with 2,763 trades. The average volume for the last 3 months is 833,777 and the stock's 52-week low/high is $3.73/$12.50.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious cannabinoid products for use on SARS-CoV-2 (COVID-19); FLGC plans to pursue the fastest path to market via a preventative immunomodulating product and to explore the possibility of use as a therapeutic. If the company’s request is approved, Flora’s formulation would be the first product containing cannabinoids to be approved for use against COVID-19 by the Colombian government. “We are honored to receive the advice and guidelines from INVIMA as we begin this exciting research process,” said Flora Growth president and CEO Luis Merchan in the press release. “The Flora Pharma division seeks to obtain evidence to support this product's use against SARS-CoV-2 and bring to market an effective, cannabinoid-based product. . . . At Flora Growth, we believe in following the research, and there have been several promising studies published in just the last few months on the application of cannabinoids in certain treatments. We are excited for our Flora Pharma researchers to build upon this progress and generate new data for how cannabis could help consumers around the world, leveraging this natural, botanical alternative.” To view the full press release, visit

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.


Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Wednesday's trading session at $1.69, off by 3.9773%, on 675,741 volume with 3,032 trades. The average volume for the last 3 months is 671,444 and the stock's 52-week low/high is $1.31/$21.45.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

Eat Well Group (CSE: EWG) (OTC: EWGFF) and CEO Marc Aneed were the focus of attention in a recent Power Play episode. The Power Play by the Market Herald is a series of interviews designed to provide interested investors with key information they need to know regarding a company’s news. The topic of conversation between Aneed and Power Play host Dave Jackson focused on the company’s recent announcement that its subsidiary, which offers Amara Organic baby food, is being distributed by HEB Grocery to an estimated 200 HEB grocery store locations across the country. The announcement noted that Amara’s recent baby food line additions included Peas, Corn & Carrots and Tropical Mango. HEB is one of the largest independently owned food retailers in the nation with more than 420 store locations. To view the full interview, visit To view the full press release, visit

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.


On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Wednesday's trading session at $0.49888, off by 6.049%, on 29,800 volume with 13 trades. The average volume for the last 3 months is 29,800 and the stock's 52-week low/high is $0.31/$1.00.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP) recently received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland. The first from a European Ethics Committee, the approval marks a significant milestone for the company as it journeys toward its potentially pivotal study of Berubicin, an anthracycline, for the treatment of Glioblastoma Multiforme (“GBM”). The approval also partly fulfills CNS’s goal of seeing Berubicin approved for the potential treatment of GBM globally. GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. “So far, the company has selected tens of clinical sites across the United States, Spain, France, Italy, and Switzerland. In addition, CNS has already dosed the first patients in its Berubicin clinical development program,” an article discussing the study reads. The recent approval, as well as the company’s dosing efforts, offer a robust foundation for a potentially pivotal global trial – an adaptive, multicenter, open-level, randomized, and controlled study that will evaluate Berubicin in adult patients with recurrent GBM (“WHO Grade IV”) after failure of standard first-line therapy. The study will evaluate overall survival, its primary endpoint. To view the full article, visit:

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $0.4991, off by 13.86%, on 763,486 volume with 1,418 trades. The average volume for the last 3 months is 759,870 and the stock's 52-week low/high is $0.493/$4.46.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

Many Americans have revealed in a new poll that they have no problem electing an individual who uses marijuana. According to the survey conducted by YouGov, 58% of the interviewees indicated that they would elect someone who takes marijuana in their free time. However, 21% wouldn’t cast that vote. The data used in the survey was collected from 4,096 individuals based in the United States. This survey comes at about the same time that Senate candidate Gary Chambers (D) released a campaign ad in which he was smoking cannabis. During the now-viral video, Chambers discusses the racial discrimination that comes with the prohibition. The growing support for marijuana legalization has thus far not translated into meaningful legal reforms at the federal level, and this must be frustrating to industry players such as Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) that have to navigate a complex legal maze just to operate in jurisdictions which have created enabling laws.

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.


Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.


Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.


Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 ( Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Wednesday's trading session at $0.4113, off by 2.2111%, on 91,726 volume with 54 trades. The average volume for the last 3 months is 91,726 and the stock's 52-week low/high is $0.289/$1.65.

Recent News

Hollywall Entertainment Inc. (OTC: HWAL)

The QualityStocks Daily Newsletter would like to spotlight Hollywall Entertainment Inc. (OTC: HWAL).

  • Hollywall Entertainment Inc. is a technology and broadcasting company using an enormous variety of resources under its corporate umbrella to extend wireless and broadband networks and related services across the country
  • Hollywall is dedicated to extending its networks to underserved or unserved communities, with a vision of improving access to technology and thereby improving socio-economic equality for opportunities and achievements
  • The company’s holdings include the rights to a catalog of over 17,500 master recordings performed by music legends ranging from Ray Charles to Rod Stewart
  • The music catalog is also being used as a means of entering the blockchain NFT space, which has enjoyed an astronomical rise in market cap during the past couple years, monetizing digital ownership of featured art

Former NBA All-Star point guard and pro basketball coach Lionel Hollins, whose most recent professional victory was as assistant coach with the Los Angeles Lakers in 2020 when he won an NBA championship ring for the second time, climbed the ladder of success from a childhood in Las Vegas where all his clothes were patched and oversized, and he was “a vegetarian before it was in vogue” out of simple necessity, as he told The Spectrum a few years earlier. Perhaps a testament to the theory that education is the great socio-economic equalizer, particularly when it included “cross-class friendships” that bridge social strata through ordinary peer exchanges to create achievement equity (, Hollins left a neighborhood where “white people didn’t exist” to attend junior college at Dixie College in Southern Utah, about 120 miles away, where he “was the only black person on the basketball team … the only black person at the college … the only black in the city,” thus beginning a storied career driven by his ambition and the help of others who mentored him, he told the newspaper ( It’s the type of story that resonates in harmony with the vision of the telecommunications and broadcasting company Hollywall Entertainment (OTC: HWAL), which is using a vast catalog of music, film, television, software and game library rights to not only build smart city, fiber network and entertainment investment profits throughout the United States, but to also create broadband access equity for many of the nation’s most vulnerable and underserved communities. 

Hollywall Entertainment Inc. (OTC: HWAL) is a telecommunication, media, technology, broadcasting and entertainment company. Through various subsidiaries, Hollywall maximizes rights to its music, film, television, software and game libraries. Hollywall owns exclusive and nonexclusive rights to market, manufacture and distribute music master recordings performed by multiple platinum-selling acts.

Hollywall was founded in 2009. The company currently has two corporate offices – one in Washington D.C. and the other in New York City.

Hollywall Entertainment Inc. (Hollywall) Subsidiaries

Hollywall has a portfolio of operating subsidiaries spanning various industries, including infrastructure development, 5G and telecommunications, broadcasting, education, media and entertainment.

Hollywall is a minority majority-controlled consortium enterprise company led by founder and President/CEO Darnell Sutton, a highly recognized visionary and award-winning business and social leader.

HWAL continues to expand its business enterprise to numerous city and state municipalities and government agencies throughout the country, including: Washington DC, New York, Virginia, Massachusetts, Pennsylvania, Texas and California, as well as within the Blackbelt regions of Alabama, Louisiana, Mississippi, Georgia and North Carolina, leading the way in developing and implementing solutions to work toward closing the broadband digital divide that has been forced upon the most vulnerable in underserved urban and rural communities nationwide.

Hollywall Development Company (“HWDC”)

HWDC builds, restores and creates “smart” cities/communities and fiber networks throughout the U.S. HWDC services, initiatives and investments include broadband and 5G networks, IOT, smart city technologies, energy, tele-medicine, tele-education, transportation, clean water, waste management and the development of green environments.

HWDC employment growth opportunities continue to attract the industry’s best, brightest and most seasoned corporate executives to join its staff, as well as its ongoing efforts to develop highly effective and profitable strategic partnerships with investment banks, global capital funds, public financial and wealth management firms, construction and engineering companies, telecommunications companies, federal agencies, state and local governments, nonprofits, faith-based organizations and housing authorities.

HWDC’s Smart Cities division aims to provide various services and solutions, such as fiber-optic networking, data centers, smart kiosks, charging stations, security and camera systems, smart traffic monitoring, emergency alert systems, gunshot detection, backup power solutions, smart connected buildings, connected and autonomous vehicles, intelligent transportation systems, advertising and more.

HW Vision and Omnipoint Technology Inc.

Hollywall Entertainment advanced its technological footprint by acquiring top United States telecommunications firm Omnipoint Technology Inc. in 2020. Through the formation of a new wholly owned subsidiary, HW Vision, Hollywall intends to offer state-of-the-art services in the continuously growing digital marketplace, such as:

  • 5G and Fiber Network installation services
  • Affordable high-speed internet access
  • Telehealth services
  • Domain hosting
  • Web conferencing
  • Managed internet services
  • Nationwide unlimited talk, text and data cellphone plans
  • Video broadcasting

In conjunction with its Omnipoint Technology partner, HW Vision has created and developed unique branding for streaming media programming, live television and on-demand content. Offerings from the HW Vision brand are expected to be available for purchase early in 2021.

Hollywall Entertainment Digital Music Network and Hollywall TV

The Hollywall Entertainment Digital Music Network (“HW Network”) has been constructed to sell single song downloads, artist album downloads and ringtones, as well as licensing music for commercial use. Hollywall Music is an owner of legacy music and video collector sets that are distributed to retail, wholesale and download or streaming services. This music library has been protected for over 20 years, and it contains some of the rarest and most coveted unpublished records by legends in the music industry.

Market Outlook

Covering various industries that are continuously expanding, such as telecommunications, media, technology, construction, infrastructure, entertainment and broadcasting, Hollywall is uniquely positioned to secure a prominent role and leverage continued growth opportunities for its subsidiaries.

The 5G sector alone could generate significant interest and market opportunities for Hollywall via HWDC and its community-focused initiatives, including the development of smart cities. The global 5G market was estimated at $41.48 billion for 2020 and is expected to reach an impressive $414.5 billion by 2027, expanding at a CAGR of 43.9% (

Management Team

Darnell Sutton is the Founder, CEO and Chairman of Hollywall Entertainment Inc. Mr. Sutton has over 40 years’ experience with many talents and vast experience as a veteran in the music recording industry, publishing, distribution, live entertainment, television, broadcasting, film and sports athlete, TV/film celebrity and artist management.

Darnell Sutton has represented and worked with some of the greatest athletes and entertainers of our time, including the “King of Pop” Michael Jackson, former heavyweight boxing champion Mike Tyson, current Welterweight Boxing Champion Floyd Mayweather, tennis superstar Serena Williams, Julius “Dr. J” Erving and incomparable multiple Grammy award-winning performers such as The Jacksons, Patti Labelle, Roberta Flack, MC Hammer, Dionne Warwick and Mariah Carey… just to name a few.

“Darnell Sutton, is one of the most exciting master communicators, creative developers and innovators of our time”…says, Tom Stein, Success Magazine.

“After many years of developing, producing and acquiring some of the world’s finest entertainment properties, we are honored to present Hollywall Entertainment companies to the marketplace. We are thrilled to join forces and work with some of the most brilliant and talented Hollywood and Wall Street executives, who have a combined shared experience of industry-recognized excellence,” Sutton said in a news release.

Roxanna Green is the Chief of Staff for Hollywall Entertainment Inc. She has over 30 years of diverse background experience ranging from corporate management to finance. Her experience includes providing corporate legal and financial guidance to both public and private companies, as well as spearheading audits, merger and acquisition negotiations, branding, marketing and public relations initiatives. She has spent the majority of her 30 years in the entertainment and media industry. She has worked with diverse institutions such as banks and securities firms, among others.

Hollywall Entertainment Inc. (OTC: HWAL), closed Wednesday's trading session at $1.25, off by 8.0882%, on 100 volume with 1 trade. The average volume for the last 3 months is 100 and the stock's 52-week low/high is $0.5551/$6.68.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

  • Friendable completed the acquisition of Artist Republik on January 4, 2022, with the Form 8-K filed with the SEC on January 10 offering an overview of that transaction
  • The acquisition of Artist Republik in conjunction with Friendable’s flagship product Fan Pass Live artist platform allows for independent artists to create, perform, produce, and distribute their music without private representation
  • President and CTO Dean Rositano was recently invited to join the Rolling Stone Culture Council, an invitation-only opportunity that sheds an additional positive light on the company within the music industry

One of the first reports in 2022 from Friendable (OTC: FDBL), a mobile technology and marketing company focused on identifying products, services, and brand opportunities with mass-market potential and scalability, was the successful acquisition of music production, distribution, marketing, and management platform Artist Republik on January 4. Friendable (OTC: FDBL), a mobile technology and marketing company, today announced significant increases in certain key metrics driving the company and the next phases of growth for its Fan Pass Live platform. Now positioned as the only 360, all-inclusive music artist platform, Fan Pass Live is quickly becoming the “anti-label” opportunity for artists who wish to maintain control yet need a support system to develop their careers and get noticed. Fan Pass offers everything from livestream and virtual events to ticket sales and merchandise — all of which drive revenue for each artist. “It’s been a steady and gradual climb as we’ve built momentum on all fronts for our Fan Pass Live platform, artists and fans. We have always been of the mindset to walk before we run, as they say, and in doing so our team was able to correctly identify our need to expand the platform beyond ‘livestream’ and support independent and anti-label artists,” said Friendable CEO Robert A. Rositano Jr. “In doing so, we are supporting their ability to be and remain independent, offering a complete set of music distribution, growth and launch services. These new offerings are showing a highly consumable nature, with a sweet spot of products and services now being offered at very reasonable prices for all artists to take advantage of. This expansion of our offering has generated a very active segment of artists that are quickly becoming repeat buyers and scaling both our revenues and metrics across the board.” To view the full press release, visit

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Wednesday's trading session at $0.002, off by 9.0909%, on 33,498,429 volume with 80 trades. The average volume for the last 3 months is 33.498M and the stock's 52-week low/high is $0.001975/$0.0649.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.